Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.31+0.17 (+7.94%)
Close on Nov 18, 2026Market cap $39.39MP/E –Yield –
Veru operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Veru's operating cash flow for the twelve months ending Jun 30, 2026 was -$26.04M. For fiscal 2025 it was -$30.04M. The highest annual figure on record is $11.79M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$30.04M | – |
| FY2024 | Sep 30, 2024 | -$21.68M | – |
| FY2023 | Sep 30, 2023 | -$88.01M | – |
| FY2022 | Sep 30, 2022 | -$47.51M | – |
| FY2021 | Sep 30, 2021 | -$15.57M | – |
| FY2020 | Sep 30, 2020 | -$1.93M | – |
| FY2019 | Sep 30, 2019 | -$5.49M | – |
| FY2018 | Sep 30, 2018 | -$11.55M | -1274.7% |
| FY2017 | Sep 30, 2017 | $982.89K | – |
| FY2016 | Sep 30, 2016 | -$1.71M | – |
| FY2015 | Sep 30, 2015 | -$1.55M | -142.3% |
| FY2014 | Sep 30, 2014 | $3.67M | -68.9% |
| FY2013 | Sep 30, 2013 | $11.79M | +13.9% |
| FY2012 | Sep 30, 2012 | $10.36M | +48.6% |
| FY2011 | Sep 30, 2011 | $6.97M | +74.6% |
| FY2010 | Sep 30, 2010 | $3.99M | -30.5% |
| FY2009 | Sep 30, 2009 | $5.75M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$5.47M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$8.91M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$6.17M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$5.49M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$5.48M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$7.74M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$11.33M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$4.37M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$5.65M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$5.65M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$6.02M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$9.49M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$18.43M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$25.56M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$34.53M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$20.88M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$14.02M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$3.95M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$8.66M | -1413.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$806.47K | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$12.83M | -484.4% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.59M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $659.24K | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$341.11K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $3.34M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$2.42M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$2.51M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$955.00K | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$527.63K | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$2.50M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$1.51M | -607.8% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$2.81M | -587.5% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$4.55M | -410.3% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$4.48M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $296.66K | -74.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $577.42K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $1.47M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$2.23M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.17M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$822.65K | – |
See a number that looks wrong?